Endocrinology
FDA/CDC
FDA committee votes yes on romosozumab for osteoporosis
FDA and the sponsor propose postmarketing surveillance to track a questionable cardiovascular safety signal.
Conference Coverage
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
From the Journals
Low-normal thyroid function tied to advanced fibrosis
In all, 5.9% of adults with low-normal thyroid function had advanced liver fibrosis, compared with 2.8% of individuals with strict-normal thyroid...
Daily News Podcast
Prenatal valproate and ADHD
The role that mothers play in the link between depression and fathers and daughters.
Conference Coverage
New diabetes drugs solidify their cardiovascular and renal benefits
CHICAGO –
Daily News Podcast
Opioids don’t top NSAIDs for chronic pain
And canakinumab has a remarkable effect on knee and hip replacement risk.
Daily News Podcast
Insulin loses its starting spot
And fewer migraines may signal greater diabetes risk in women.
From the Journals
BMI compares favorably with body scanning for ID of cardiometabolic traits
BMI may be all that’s needed to identify metabolic risk factors in young persons.
Daily News Podcast
ABIM sued over maintenance of certification
Do weight loss drugs have a role following bariatric surgery?
From the Journals
PCOS linked to increased cancer risk in premenopausal women
The increased risks appear to subside after menopause.